1.
Bioorg Med Chem Lett
; 11(17): 2229-34, 2001 Sep 03.
Artículo
en Inglés
| MEDLINE
| ID: mdl-11527704
RESUMEN
A synthesis program directed toward improving the stability of imidoyl thiourea based non-nucleoside reverse transcriptase inhibitors (NNRTIs) led to the discovery of diaryltriazines (DATAs), a new class of potent NNRTIs. The synthesis and anti-HIV structure-activity relationship (SAR) studies of a series of DATA derivatives are described.
Asunto(s)
Fármacos Anti-VIH/química , Fármacos Anti-VIH/farmacología , Transcriptasa Inversa del VIH/antagonistas & inhibidores , Fármacos Anti-VIH/síntesis química , Diseño de Fármacos , Transcriptasa Inversa del VIH/genética , VIH-1/efectos de los fármacos , VIH-1/genética , Concentración 50 Inhibidora , Inhibidores de la Transcriptasa Inversa/química , Inhibidores de la Transcriptasa Inversa/farmacología , Relación Estructura-Actividad , Triazinas/química
2.
Bioorg Med Chem Lett
; 11(17): 2235-9, 2001 Sep 03.
Artículo
en Inglés
| MEDLINE
| ID: mdl-11527705
RESUMEN
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Several members of this novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) are extremely potent against both wild-type and a panel of clinically significant single- and double-mutant strains of HIV-1.